Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery and evaluation of cytisine N-isoflavones as novel EGFR/HER2 dual inhibitors
Yanqing Wang, Xiaoying Yin, Ling‐Yan Chen, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105868-105868
Closed Access | Times Cited: 14

Showing 14 citing articles:

Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight
Rutuja Damare, Kritika Engle, Gautam Kumar
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2406-2447
Closed Access | Times Cited: 10
Quinolizidine Alkaloids and Isoflavones from the Herb of Thermopsis lupinoides and Their Antiviral, Antifungal, and Insecticidal Activities
Tong Zhang, Cai-Yan Tian, Ji Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 9, pp. 5047-5061
Closed Access | Times Cited: 4
Total Syntheses and Antibacterial Studies of Natural Isoflavones: Scandenone, Osajin, and 6,8-Diprenylgenistein
Hongbo Dong, Yufei Che, Xingtong Zhu, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2574-2574
Open Access | Times Cited: 4
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 8
Dalbergia sissoophytochemicals as EGFR inhibitors: anin vitro and in silicoapproach
Hem N. Naik, Dilip Kanjariya, Shahnaz Parveen, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 10, pp. 5415-5427
Closed Access | Times Cited: 6
Identification of a Cryptic Binding Site in CRISPR-Cas9 for Targeted Inhibition
Niu Zhang, Zhicheng Zuo
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 11, pp. 3500-3509
Closed Access | Times Cited: 4
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
Meduri Bhagyalalitha, Akshatha Handattu Shankaranarayana, Sethu Arun Kumar, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107695-107695
Closed Access
Cornulacin: a new isoflavone from Cornulaca monacantha and its isolation, structure elucidation and cytotoxicity through EGFR-mediated apoptosis
Ahmed M. Badawy, Enas E. Eltamany, Rodina M. Hussien, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3228-3238
Open Access
Matrine alkaloids modulating DNA damage repair in chemoresistant non-small cell lung cancer cells
Fengping Wang, Jun Liu, Wenliang Liao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Synthesis and neuroprotective activity of a (–)-cytisine-isoflavone conjugate
Li Tang, Ling‐Yan Chen, Zi-Hao Jia, et al.
Chemistry of Heterocyclic Compounds (2023) Vol. 59, Iss. 1-2, pp. 41-47
Closed Access | Times Cited: 1
Three new quinolizidine alkaloids from the roots of Sophora tonkinensis
Qiao An, Ji Zhang, Peng Zhang, et al.
Journal of Asian Natural Products Research (2023) Vol. 26, Iss. 3, pp. 302-312
Closed Access | Times Cited: 1
Structure–Activity Relationship Prediction‐Based Synthesis and Cytotoxicity Evaluation against the HEp‐2 Laryngeal Carcinoma Cell of Isoflavone–Cytisine Mannich Bases
Galyna P. Mrug, Diana Hodyna, Larysa Metelytsia, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 8
Open Access | Times Cited: 1
Identifying natural products for gastric cancer treatment through pharmacophore creation, 3D QSAR, virtual screening, and molecular dynamics studies
Zeinab Jalali, Samad Nejad Ebrahimi, Hassan Rezadoost
DARU Journal of Pharmaceutical Sciences (2023) Vol. 31, Iss. 2, pp. 243-258
Open Access | Times Cited: 1
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management
Alessia Filippone, Deborah Mannino, Giovanna Casili, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15693-15693
Open Access | Times Cited: 1
Page 1

Scroll to top